Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
These practical considerations often prove decisive in real-world decision making
Most clinical pathways look like this: Diagnose OSA with a sleep test (home or in-lab) Start CPAP for immediate symptom relief and cardiovascular protection Concurrently start tirzepatide if the patient qualifies and wants weight loss After 6 to 12 months, repeat the sleep study to measure new AHI If AHI is below 5, consider weaning off CPAP under physician supervision Some patients reach normal AHI on tirzepatide alone and stop CPAP
Starting Treatment Eligibility: Standard eligibility requires BMI of 30 or higher, or BMI 27 or higher with a weight-related condition
Some patients feel full at lower doses and may stay at 0.25 mg or 0.5 mg long-term, while others gradually escalate to find their individual therapeutic sweet spot
Patients uncertain about their technique should request a review with their diabetes specialist nurse or practice nurse, who can observe their method and provide personalised guidance
Get savings and support for Rybelsus
US$ 21.78
US$ 28.96
US$ 28.07
US$ 22.82
US$ 25.75
US$ 29.37
US$ 25.51
